Upal Basu Roy/LinkedIn
Oct 9, 2024, 15:23
Upal Basu Roy: How immune cells can be engineered to target EGFR+ NSCLC
Upal Basu Roy, Executive Director of Research at LUNGevity Foundation, shared about a Facebook Live event hosted by LUNGevity Foundation. Read his post on LinkedIn below:
“Are you interested in learning about EGFR-positive non-small cell lung cancer?
Please join me for a Facebook Live event hosted by LUNGevity Foundation that explores how immune cells can be engineered to target EGFR+ NSCLC.
- Date: Thursday, October 10
- Time: 12 PM Eastern Time
- Where: Tune in here
Joining me will be Jill Feldman and Laura Book from the EGFR Resisters, along with Alexandre Reuben, PhD from the MD Anderson Cancer Center. Dr. Reuben received a 2023 EGFR Resisters/LUNGevity Foundation grant.
I hope to see you there!”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 07:45
Dec 21, 2024, 05:54
Dec 21, 2024, 05:42
Dec 21, 2024, 04:55